Combination of serum markers related to several mechanisms in Alzheimer’s disease

Charlotte E. Teunissen; Dieter Lütjohann; Klaus von Bergmann; Frans R.J. Verhey; F.W. Vreeling; Annick Wauters; E. Bosmans; Hans Bosma; Martin P.J. van Boxtel; Michael Maes; Joris R. Delanghe; Henk J. Blom; Marcel M. Verbeek; Peter Rieckmann; C. De Bruijn; H.W.M. Steinbusch; Jan de Vente

doi:10.1016/s0197-4580(03)00005-8

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2022

Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia

Germán Plascencia‐Villa, George Perry

Article2006

P1–209: Relations of serum inflammatory markers and monocyte production of cytokines to the risk for Alzheimer's disease: The Framingham study

Zaldy S. Tan, Sudha Seshadri, Alexa S. Beiser, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia Benjamin, Rhoda Au, Douglas P. Kiel, Ramachandran S. Vasan, Philip A. Wolf

Article2004

Therapeutic potential of oxidant mechanisms in Alzheimer’s disease

Paula I. Moreira, Mark A. Smith, Xiongwei Zhu, Maria S. Santos, Catarina R. Oliveira, George Perry

Article2007

Inflammatory markers and the risk of Alzheimer disease

Zaldy S. Tan, Alexa S. Beiser, Ramachandran S. Vasan, Ronenn Roubenoff, Charles A. Dinarello, Tamara B. Harris, Emelia Benjamin, Rhoda Au, Douglas P. Kiel, P. A. Wolf, Sudha Seshadri

Chapter in a book2006

Mechanisms of DNA Damage and Repair in Alzheimer Disease

V. Prakash Reddy, George Perry, Marcus S. Cooke, Lawrence M. Sayre, Mark A. Smith